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Stroke is a leading cause of death worldwide, contributing to over 
10% of all deaths annually, and this is expected to rise due to an 
aging population. The incidence of stroke increases dramatically with 
age, with an estimated 70%–80% of all ischaemic strokes occurring 
in people above the age of 65 (Ovbiagele & Nguyen‐Huynh, 2011). 
Studies have highlighted the significance of age in worsening stroke 
severity, functional improvement and overall outcomes (Manwani et 
al., 2011; Ritzel et al., 2018; Yager, Wright, Armstrong, Jahraus, & 
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Abstract
Bacterial infection a leading cause of death among patients with stroke, with elderly 
patients often presenting with more debilitating outcomes. The findings from our 
retrospective study, supported by previous clinical reports, showed that increasing 
age is an early predictor for developing fatal infectious complications after stroke. 
However, exactly how and why older individuals are more susceptible to infection 
after stroke remains unclear. Using a mouse model of transient ischaemic stroke, we 
demonstrate that older mice (>12 months) present with greater spontaneous bac‐
terial lung infections compared to their younger counterparts (7–10 weeks) after 
stroke. Importantly, we provide evidence that older poststroke mice exhibited el‐
evated intestinal inflammation and disruption in gut barriers critical in maintaining 
colonic integrity following stroke, including reduced expression of mucin and tight 
junction proteins. In addition, our data support the notion that the localized pro‐in‐
flammatory microenvironment driven by increased tumour necrosis factor‐α produc‐
tion in the colon of older mice facilitates the translocation and dissemination of orally 
inoculated bacteria to the lung following stroke onset. Therefore, findings of this 
study demonstrate that exacerbated dysfunction of the intestinal barrier in advanced 
age promotes translocation of gut‐derived bacteria and contributes to the increased 
risk to poststroke bacterial infection.
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Saucier, 2006). Specifically, the adverse biological effects of normal 
aging, such as cell senescence, low‐grade systemic inflammation and 
decline in immune function, can impend on events critical to recov‐
ery after stroke and contribute to the poor prognosis in the elderly 
(Licastro et al., 2005; Ritzel et al., 2018; Wen & Wong, 2018).
Despite its well‐recognized primary effects on the brain, a major 
cause of death after stroke is infection: a poststroke complication 
that has received increasing attention for its large clinical implica‐
tions (Shim & Wong, 2018). In fact, more than 30% of infected pa‐
tients with stroke die of infection as a secondary complication within 
a week of stroke onset, with infection of the respiratory (bacterial 
pneumonia) and urinary tracts most prevalent (Meisel, Schwab, 
Prass, Meisel, & Dirnagl, 2005). Advanced age and stroke severity 
are known early predictors for poor patient outcome after stroke 
(Wartenberg et al., 2011), possibly due to elevated risk of infection, 
but the underlying mechanisms are unclear.
Randomized clinical trials evaluating prophylactic antibiotics in 
patients with acute stroke showed that this therapeutic approach 
did not lower the incidence of poststroke pneumonia (Kalra et al., 
2015), and it was not associated with reduced mortality or improved 
functional outcomes (Xi et al., 2017). These trials suggest a clear 
need for alternative treatment approaches, and importantly, a better 
understanding of the underlying mechanisms of poststroke infec‐
tions. Associative clinical studies speculate that risk factors for post‐
stroke pneumonia include dysphasia, nasogastric tubing, catheters, 
mechanical ventilation and aspiration (Chapman, Morgan, Cadilhac, 
Purvis, & Andrew, 2018). In addition, the age‐related decline in im‐
mune functions may further increase susceptibility of the elderly to 
poststroke infection (Crapser et al., 2016; Ritzel et al., 2018; Shaw, 
Goldstein, & Montgomery, 2013). While these factors may play an 
important role, our recent work demonstrated that poststroke in‐
fection may also originate from dissemination of gut commensal 
bacteria to peripheral tissues (Stanley et al., 2016). Indeed, >70% 
of the microorganisms detected in infected stroke patients of the 
studied cohort were common commensal bacteria that reside in the 
human intestinal tracts (e.g., Enterococcus spp., Escherichia coli and 
Morganella morganii) (Stanley et al., 2016). Unfortunately, a major 
caveat to these findings that demonstrate a vital brain‐gut link in 
the setting of stroke is that the effect of age was not assessed and 
warrants further investigation. As such, in this study, we examined 
if advanced age can promote the translocation and dissemination of 
commensal bacteria to potentiate the development of poststroke 
infection.
2  | RESULTS
2.1 | Advanced age is a risk factor for the 
development of infection in patients after acute 
stroke
A total of 633 patient records were obtained from the Monash 
Medical Centre, where 124 did not meet the inclusion criteria and 
were hence excluded, leaving a total of 509 within the study co‐
hort. Patient cohort characteristics are summarized in Table 1. The 
mean patient age was 71.4 years (standard deviation [SD]: 14.5) with 
almost half being female (n = 226, 44.4%). A majority of patients 
presented with ischaemic strokes (n = 432, 84.9%) compared to 
haemorrhagic strokes (n = 77, 15.1%), but patients of the two stroke 
subtypes were similar with respect to age and sex distributions. A 
total of 55 (10.8%) patients from the cohort presented with a definite 




Age (mean/SD) 71.4 (SD: 14.5)
Female sex 226 (44.4%)
Days in acute ward (median) 4.5





Prevalence of infection 55 (10.8%)
Day of onset of infection (mean) 3.63
Site of infection (% of infected)
Eye/ENT 1 (1.9%)
Gastrointestinal 1 (1.9%)
Lung (except pneumonia) 2 (3.7%)
Pneumonia 21 (38.9%)
Skin/Soft tissue 1 (1.9%)
Urinary tract 24 (44.4%)
Unknown 1 (1.9%)
Multiple 4 (7.4%)
Antibiotics prescribed 66 (13.0%)
IV line inserted 501 (98.4%)
IDC inserted 73 (14.3%)
NGT inserted 37 (7.3%)
ETT inserted 23 (4.5%)
Co‐morbid conditions
Diabetes 122 (24.0%)
Chronic lung disease 49 (9.6%)
Chronic liver disease 6 (1.2%)
Malignancy 63 (12.4%)
HIV 0 (0.0%)




Antibiotics (prestroke) 17 (3.3%)
Abbreviations: ENT, ear, nose and throat; ETT, endotracheal tube; HIV, 
human immunodeficiency virus; IDC, indwelling urethral catheter; IV, 
intravenous; NGT, nasogastric tube; SD, standard deviation.
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new case of infection after stroke as defined by the CDC/NHSH cri‐
teria. The most common types of infections were urinary tract infec‐
tions (n = 24, 44.4% of all infections) and pneumonia (n = 21, 38.9%). 
Patients with multiple infections (n = 4, 7.4%) and other infections 
(eye/ear/nose/throat, gastrointestinal, other respiratory infections 
excluding pneumonia, skin/soft tissue, and unknown) were much 
less prevalent (n = 1, 1.8%).
Multivariable logistic regression modelling was used to deter‐
mine the association between stroke and the presence of infection 
after adjusting for confounding factors: age, sex, stroke severity 
(NIHSS), immune‐suppressants, the presence of co‐morbidities, the 
use of indwelling urinary catheter (IDC) and the presence of naso‐
gastric tube (NGT) feeding (Table 2). Multivariable regression model 
of risk factors analysis showed that age (OR 1.04, 95% 1.01–1.07), 
stroke severity (OR 1.05, 95% 1.01–1.08) and the use of an indwell‐
ing catheter (OR 7.79, 95% 3.62–16.74) had a significant association 
with poststroke infection and hence are independent predictors 
(p < 0.05; Table 2). Conversely, stroke type, sex, co‐morbid condi‐
tions and the use of immunosuppressive medications, beta‐blockers, 
prestroke antibiotics and NGT were not independently associated 
with infection risk (Table 2).
2.2 | Advanced age exacerbates lung infection in 
poststroke mice
In this study, we chose to use 12‐ to 15‐month‐old mice for mod‐
elling advanced age and denoted this group as “older.” Significant 
mortality rate (44%) after stroke was recently reported with the use 
of animals >18 months old (Ritzel et al., 2018), as such we selected 
12‐ to 15‐month‐old mice to represent our “older” group in order to 
avoid studying survival bias.
To assess the effect of advanced age on injury lesion develop‐
ment after the mild model of stroke, we performed preclinical mag‐
netic resonance imaging (MRI) on our young and older cohort of 
animals at 24 hr following stroke onset. We observed similar oedema 
volumes after stroke between the two groups of mice (Figure 1a), but 
mice in the older group showed enhanced neurological impairment 
compared with younger counterparts (Figure 1b). This is consistent 
with the well‐reported clinical observations that elderly patients 
often present with greater neurological impairment and more de‐
bilitating outcomes after stroke. To understand how advanced age 
contributes to the development of poststroke infection, we quanti‐
fied the amount of culturable bacteria from lung homogenates 24 hr 
after stroke. Older mice demonstrated a 100‐fold increase in cul‐
turable bacteria after stroke compared with sham‐operated controls 
and young counterparts, suggesting an impairment of antimicrobial 
defence in advanced age after stroke (Figure 1c). Levels of culturable 
bacteria in the blood, liver, mesenteric lymph node (MLN) and spleen 
remained similar and largely undetectable for both older and young 
mice after stroke when compared to their respective sham‐operated 
animals (Figure S1).
2.3 | Older mice exhibit greater colonic 
permeability poststroke
Our previous study using a more severe model of transient stroke in 
young mice (7–10 weeks old) showed that poststroke infection is at‐
tributable to intestinal dysfunction and the subsequent systemic dis‐
semination of host intestinal bacteria (Stanley et al., 2016). However, 
we are yet to understand whether age contributes to this phenom‐
enon. To examine the effect of advanced age on gut permeability, 
we assessed the translocation of orally gavaged fluorescein‐iso‐
thiocyanate‐labelled dextran (FITC‐dextran) into the bloodstream. 
While no difference in small intestine permeability was observed in 
this mild model of stroke (Figure 2a), colonic permeability was sig‐
nificantly increased exclusively in older mice after stroke compared 
with their sham‐operated controls (Figure 2b). This rise in colonic 
permeability was not accompanied by changes in vascular perme‐
ability as determined by the detection of Evans blue dye in intestinal 
tissue (Figure 2c). Furthermore, while older poststroke mice did not 
demonstrate visible clinical signs of colonic damage (i.e., stool incon‐
sistency or faecal occult blood) compared with sham‐controls, older 
animals clearly displayed worse colonic inflammation and injury mi‐
croscopically than their young counterparts as assessed by histology 
in a blinded manner (Figure 2d).
2.4 | Older mice show evidence of colonic barrier 
breakdown poststroke
Integrity of the colonic barrier encompasses many structural and 
physiochemical aspects that collaborate to regulate intestinal per‐
meability and prevent bacterial translocation (Chelakkot, Ghim, & 
Ryu, 2018). The intestinal mucosal layer consists of mucin produced 
by goblet cells, together with secretory IgA, which form the cru‐
cial first line of defence. At 24 hr after stroke, there was a signifi‐
cant increase in goblet cell numbers in the colon of both young and 
older mice compared with their respective sham‐operated controls 
TA B L E  2   Multivariable logistic regression model of risk factors 
associated with infection after acute stroke
 OR (95% CI) p‐Value
Stroke type 1.17 (0.50–2.73) 0.72
Age 1.04 (1.01–1.07) 0.01*
Sex (Female) 0.84 (0.43–1.64) 0.62
NIHSS 1.05 (1.01–1.08) 0.02*
Co‐morbidities 1.13 (0.58–2.23) 0.72
Use of beta‐blockers 1.48 (0.77–2.82) 0.24
Use of immune‐suppressants 1.59 (0.54–5.16) 0.37
Use of antibiotics prestroke 1.70 (0.38–7.65) 0.11
Use of NGT 2.18 (0.84–5.64) 0.11
Use of IDC 7.79 (3.62–16.74) <0.001*
Abbreviations: CI, confidence interval; IDC, indwelling urethral cath‐
eter; NGT, nasogastric tube; NHISS, National Institutes of Health Stroke 
Scale; OR, odds ratio.
*p < 0.05 values indicate statistical significance. 
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(Figure 3a). Interestingly, gene expression of key components that 
form the mucus layer, mucin 2 (Muc2), mucin 4 (Muc4) and mucin 13 
(Muc13) was decreased only in the older mice, but not in young mice, 
after stroke (Figure 3b). This reduction in mucin expression suggests 
a potential age‐dependent breakdown of the mucus barrier follow‐
ing stroke onset. Conversely, the levels of secretory IgA in the serum 
and colon remained unaltered after stroke (Figure 3c,d). However, it 
was noted that serum IgA expression was elevated in older animals 
independent of stroke when compared to younger counterparts 
(Figure 3c).
2.5 | Reduced tight junction protein expression in 
older mice after stroke
Beyond the first line of defence, the colonic barrier is strength‐
ened further by important multi‐complex tight junctions that en‐
sure strong scaffolding of intestinal epithelial and endothelial cells 
(Chelakkot et al., 2018). Alterations in the protein expression of tight 
junctions can lead to intestinal structure disruption and changes to 
paracellular and intercellular barrier permeability. Using immuno‐
fluorescence staining, we observed that the expression of key pro‐
teins of the tight junction complex, zonula occludens‐1 (ZO‐1), was 
reduced exclusively in the colon of older mice after stroke, and not 
their young counterparts (Figure 4a). This pattern of reduced ex‐
pression appeared specific to ZO‐1 as it was not statistically differ‐
ent across gene expressions of other prominent tight junctions in the 
colon or small intestine of older poststroke mice: occluden (Ocldn), 
junctional adhesion molecule (JAM‐A), claudin 3 (Cldn3) and claudin 
5 (Cldn5) (Figure 4b–e and Figure S2).
2.6 | Tumour necrosis factor‐α facilitates the 
breakdown of colonic barriers poststroke
Given that older mice showed greater histological evidence of in‐
testinal inflammation than their younger counterparts (Figure 2d), 
we hypothesized that the stroke‐induced pro‐inflammatory micro‐
environment promotes barrier breakdown in the colon of older mice. 
Indeed, previous studies have reported that pro‐inflammatory cy‐
tokines, specifically tumour necrosis factor (TNF‐α), play a critical 
role in regulating tight junction proteins in a myosin light chain kinase 
(MLCK)‐dependent manner, inducing intestinal permeability, pathol‐
ogy and inflammaging (Shen, 2012; Yu et al., 2010). In this study, ex‐
pression of TNF‐α and IL‐10 was elevated exclusively in the colonic 
tissue of older, and not young mice 5 hr poststroke compared with 
sham‐operated cohorts (Figure 5a,b): a time point that preceded any 
changes in tight junction expression of Cldn3, Cldn5, Ocldn and ZO‐1 
(Figure S3). Additionally, we found no difference in the total number 
of CD45+ leucocytes, CD3+ T cells, CD11b+ myeloid cells, Ly6G+/
Ly6C− neutrophils or Ly6G−/Ly6C+ monocytes in the colon, suggest‐
ing this early pro‐inflammatory cytokine environment was not be 
driven by cellular immune changes (Figure S4). By 24 hr poststroke, 
elevated TNF‐α and IL‐10 expression in the colon of older poststroke 
mice returned back to baseline sham levels (Figure S5A,B). The ear‐
lier acute pro‐inflammatory response appears specific to the colon 
as circulating serum levels of TNF‐α and IL‐10 remain unchanged at 
both the 5‐ and 24‐hr time point following stroke (Figure 5c,d and 
Figure S5C,D).
Tumour necrosis factor‐α signalling has been shown to par‐
ticipate in cerebral neuroinflammation after stroke (Hallenbeck, 
F I G U R E  1   Advanced age exacerbates 
neurological impairment and lung 
infection poststroke. The following 
assessments were performed 24 hr after 
mid‐cerebral artery occlusion induction on 
young (7–10 weeks) and older (12–
15 months) mice: (a) preclinical magnetic 
resonance imaging (MRI) to assess volume 
of brain oedema (n = 6/group). Oedema 
region indicated within yellow outline; 
(b) neurological assessment (n = 14–16/
group); (c) bacteriological analysis of 
lung homogenates to assess poststroke 
lung infection (n = 6–8/group). Data 
represent the mean ± SEM. Significance 
was determined by Mann–Whitney U 



























































     |  5 of 13WEN Et al.
2002); thus, the use of anti‐TNF‐α or recombinant TNF‐α to ex‐
amine its role in stroke‐induced gut dysfunction in vivo may also 
impact brain infarct development. Therefore, to firstly confirm the 
critical role of TNF‐α with advancing age on the regulation of tight 
junction complexes independent of brain ischaemic alterations as 
a confounding factor, we adopted an ex‐vivo strategy. Cross sec‐
tions of colon from naïve older mice were treated with recombi‐
nant TNF‐α for 1 hr in an ex‐vivo setting to mimic the induction of 
stroke‐induced pro‐inflammatory responses, and changes in gene 
expression of various tight junctions assessed. We found that 
TNF‐α treatment significantly reduced colonic gene expression 
of Cldn3, Cldn5, JAM‐A and Ocldn compared to untreated colons 
(Figure 5e), suggesting disruption of intestinal barriers. In separate 
experiments, to examine the contribution of TNF‐α in facilitating 
gastrointestinal permeability in an in vivo stroke setting, we ad‐
ministered recombinant TNF‐α (or saline i.p. as control) to young 
sham‐operated and poststroke mice, and assessed FITC‐dextran 
translocation into the bloodstream. It is important to note that 
both of these groups with young mice did not show evidence of 
intestinal dysfunction without the treatment of TNF‐α (Figure 2b). 
In the setting of stroke, administration of TNF‐α induced greater 
gastrointestinal permeability as indicated by a trend towards in‐
creased serum levels of orally gavaged FITC‐dextran compared to 
their corresponding saline‐treated mice (Figure 5f). Importantly, 
the ability of TNF‐α to regulate intestinal permeability is depen‐
dent on the induction of stroke as sham‐operated young mice with 
TNF‐α treatment were unaffected (Figure 5f). Taken together, our 
data suggest that early production of TNF‐α localized in the colon 
in older poststroke mice can robustly down regulate the expres‐
sion of a number of tight junction proteins and contribute to the 
breakdown of colonic barriers.
2.7 | Enhanced bacterial translocation in older mice 
after stroke
With various components of the intestinal barrier showing dys‐
function and enhanced gut inflammation after stroke in older 
mice, we next assessed if these components in combination can 
F I G U R E  2   Colonic permeability increases with age after stroke. Serum levels of orally gavaged fluorescein‐isothiocyanate‐labelled 
(FITC)‐dextran were quantified from mid‐cerebral artery occlusion (MCAO) or sham mice to examine permeability of the (a) small intestine 
and (b) colon. (c) Extravasation of Evans blue dye from the colon was quantified 24 hr after MCAO or sham surgery as an indicator of 
vascular permeability. (d) Representative H&E images of colonic crypts at 100× magnification (scale bar = 2 mm). Histological scores 
for various parameters were totalled to indicate the degree of colonic pathology. A higher score indicates more visible clinical signs of 
colonic damage (n = 4–8/group). Black arrows denote examples of crypt damage and loss of architecture. Data represent the mean ± SEM. 
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promote the translocation and systemic dissemination of colonic 
bacteria. We orally gavaged a streptomycin‐resistant derivative 
of an E. coli strain to young and older mice 3 hr after stroke or 
sham surgery, a time point when gut permeability was evident. 
The lungs, faeces, caecum, colon and various sections of the 
small intestine (duodenum, jejunum, ileum) were assessed for the 
presence of streptomycin‐resistant E. coli, 24 hr postinoculation 
(Figure 6a). Both young and older mice had significantly higher 
levels of streptomycin‐resistant E. coli in the caecum and faeces 
after stroke onset (Figure 6b,c). Conversely, detectable levels of 
streptomycin‐resistant E. coli remained unchanged in the colon, 
duodenum, jejunum and ileum after stroke (Figure 6d and Figure 
S6). Importantly, we noted that while all older mice after stroke 
had detectable levels of streptomycin‐resistant E. coli in their 
lungs, these bacteria remained almost undetectable in sham‐op‐
erated controls and young counterparts (Figure 6e). Therefore, 
the results of this inoculation experiment strongly suggest the 
stroke‐induced colonic inflammation and permeability observed in 
the older mice may contribute to the translocation of commensal 
bacteria for systemic dissemination.
3  | DISCUSSION
Aside from neurological damage, bacterial pneumonia is the most 
frequent severe complication, and the most common cause of death, 
in patients with stroke (Meisel et al., 2005; Shim & Wong, 2018). 
Confirming previous clinical studies, we showed using a retrospec‐
tive patient cohort that increasing age is an independent predictor 
for developing infection after stroke. Further to this, we utilized an 
experimental model of mild transient ischaemic stroke to examine 
how advance age may render the host more susceptible to poststroke 
infection. The present study demonstrated that the frequency and 
severity of poststroke infections are greater in older animals com‐
pared with their younger counterparts. This age‐dependent onset 
of poststroke pneumonia is attributed to increased colonic inflam‐
mation, permeability, structural breakdown and bacterial transloca‐
tion to peripheral tissues such as the lung, where they may become 
pathogenic to worsen overall disease outcomes.
A growing number of experimental and clinical studies suggest 
that altered signalling between the brain, gut and microbiota is impli‐
cated in several neurological disorders, including autism, Parkinson's 
disease, Alzheimer's and stroke (Sharon, Sampson, Geschwind, & 
Mazmanian, 2016; Stanley, Moore, & Wong, 2018). In fact, gastro‐
intestinal dysfunction is a common complication in patients with 
head injuries (Pilitsis & Rengachary, 2001). This is unsurprising 
since the central nervous system (CNS) modulates the highly inner‐
vated gastrointestinal tract by branches of the autonomic nervous 
system and the hypothalamic/pituitary/adrenal (HPA) axis (Rao & 
Gershon, 2016). In the setting of stroke, up to 50% of patients ex‐
perience pathophysiological changes in the gastrointestinal tract, 
including dysphagia, gastrointestinal bleeding and constipation 
F I G U R E  3   Stroke induces robust mucosal changes in older animals. (a) Representative images of colonic goblet cells at 100× 
magnification (scale bar = 2 mm; black arrow), stained using PAS‐Alcian blue at 24 hr postsurgery (n = 4–5/group). (b) Gene expression of 
mucin 2 (Muc2), Muc4 and Muc13 from the colon of young and older mice was analysed by qPCR 24 hr after mid‐cerebral artery occlusion 
(MCAO) and expressed as a fold change relative to that of young sham‐operated controls (n = 7/group). (c) Protein levels of secretory IgA in 
the serum and (d) colon 24 hr after MCAO or sham surgery (n = 7–8/group). Data represent the mean ± SEM. Significance was determined 
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(Camara‐Lemarroy, Ibarra‐Yruegas, & Gongora‐Rivera, 2014). 
Gastrointestinal complications after stroke are associated with over‐
all poor patient outcomes, including delayed patient recovery times, 
increased mortality rates and deteriorating neurologic function 
(Camara‐Lemarroy et al., 2014; Paciaroni et al., 2004). Indeed, the 
findings from our current study indicate that advanced age exacer‐
bates the risk of gastrointestinal dysfunction after mild brain injury. 
Despite similar brain oedema volumes between young and older 
mice after stroke, only older animals demonstrated rapid colonic al‐
terations within 24 hr after stroke. The colon of older stroke mice 
showed significant breakdown of barriers that help maintain gut 
integrity, including reduced expression of mucin and tight junction 
proteins. This breakdown was sufficient to allow the translocation 
of orally inoculated bacteria (streptomycin‐resistant E. coli) from the 
gut to peripheral tissues. While we cannot confirm from our clinical 
and experimental studies that stroke‐induced spontaneous lung in‐
fection results directly from translocated host gut microbiota, one 
may speculate that it is a possible cause. Supporting this idea, we 
have previously shown that the majority (>70%) of bacteria detected 
in patients with stroke at a median age of 76.5 who developed infec‐
tions were common commensal bacteria that normally reside in the 
intestinal tract (Enterococcus spp., E. coli and M. morganii; Stanley et 
al., 2016). Further studies to examine whether only select bacterial 
types from the colon are capable of translocation, survival and ex‐
pansion in peripheral tissues, such as the lung, poststroke are re‐
quired. Additionally, examining how this selectivity changes with 
increasing age would be important in the quest for novel therapies 
independent of antibiotics.
Previous work has shown that significant adverse effects of 
normal aging, such as chronic inflammation and decline in innate 
immune function, can impend on events critical to recovery after 
stroke and contribute to poor prognosis in the elderly (Crapser et al., 
2016; Ritzel et al., 2018). We additionally show in the present study 
that excessive induction of pro‐inflammatory responses localized in 
the gut can disrupt intestinal function and may contribute to worse 
stroke outcomes for older individuals. Indeed, we showed that the 
compromised intestinal barriers following stroke in older animals 
were associated with the early and increased production of pro‐in‐
flammatory TNF‐α. This is consistent with previous studies showing 
that anti‐TNF therapy reverses the negative effects of age‐associ‐
ated inflammation and microbial dysbiosis on intestinal permeability 
and bacterial translocation (Thevaranjan et al., 2017). The mecha‐
nistic regulation of TNF‐α on tight junction proteins such as ZO‐1 
is highly complex, but morphological studies using cell lines and in 
vivo imaging techniques have shown its interaction and resulting re‐
sponse can happen quickly. It is believed TNF‐α interacts with ZO‐1 
F I G U R E  4   Age‐dependent disruption of colonic tight junctions after stroke. (a) Representative immunofluorescence images of colonic 
cross sections at magnification of 400× (scale bar = 50 µm), stained for nuclei (DAPI; blue), EpCAM (Alexa Fluor 488; green) and ZO‐1 (Alexa 
Fluor 568; red). The area of ZO‐1 staining relative to DAPI staining was quantified 24 hr after mid‐cerebral artery occlusion (MCAO) or sham 
surgery (n = 5/group). The gene expression of (b) occludin (Ocldn), (c) junctional adhesion molecule‐A (JAM‐A), (d) claudin 3 (Cldn3) and (e) 
claudin 5 (Cldn5) from the colon of young and older mice was analysed by qPCR 24 hr after MCAO and expressed as a fold change relative 
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to induce cytoskeletal reorganization via modulation of myosin light 
chain kinase (MLCK) activity, resulting in changes to the perijunc‐
tional actomyosin ring structure critical for cell anchorage (Yu et al., 
2010). TNF‐α can additionally induce occludin removal through ca‐
veolar endocytosis to affect structural and functional tight junction 
regulation (Marchiando et al., 2010). The likely source of elevated 
TNF‐α in the colon of older poststroke mice is the damaged intes‐
tinal epithelium, as the immune composition of the gut and serum 
concentrations of this pro‐inflammatory cytokine remained un‐
changed after stroke. In fact, TNF‐α production by intestinal epithe‐
lial cells has been shown to be key in initiating pathology in Crohn's 
disease (Roulis, Armaka, Manoloukos, Apostolaki, & Kollias, 2011). 
Therefore, specific inhibition of TNF‐α production by the intestinal 
epithelium may present a new strategy to reduce gut permeability 
and subsequently gut‐derived bacterial lung infection after stroke.
We have previously shown that young mice subjected to a more 
severe model of transient stroke resulted in dysfunction of the small 
intestine but not the colon (Stanley et al., 2016). The subsequent 
systemic dissemination of gut‐derived bacteria from the small intes‐
tine was driven by sympathetic neural signalling as pharmacological 
administration of β‐adrenergic receptor inhibitors (propranolol or 
metoprolol) restored stroke‐induced ileum dysfunction and reduced 
poststroke infection. Another study using multiple experimen‐
tal stroke models also showed that only large stroke lesions cause 
barrier dysfunction, reduced motility and microbiota dysbiosis of 
the small intestine in younger mice (Singh et al., 2016). It is feasi‐
ble that the degree of intestinal dysfunction and location resulting 
from stroke is dependent on a variety of factors highly influenced 
by the process of aging: intestinal regeneration and repair, sympa‐
thetic drive, gut inflammatory state, immune composition and func‐
tion, and the existing host microbiota. Indeed, our study showed 
that older animals displayed worse colonic inflammation and injury 
microscopically prior to stroke induction when compared to younger 
counterparts, indicating innate biological differences with age. 
Consistent with these findings, a recent study demonstrated that 
older mice showed increased apoptotic cells in intestinal crypts and 
F I G U R E  5   Tumour necrosis factor (TNF)‐α may facilitate the breakdown of colonic barriers poststroke. Protein expression of TNF‐α 
and IL‐10 in the (a–b) colon and (c–d) serum from young and older mice was quantified 5 hr after mid‐cerebral artery occlusion (MCAO) or 
sham surgery (n = 5–8/group). (e) Colon cross sections from naïve older mice were treated with recombinant TNF‐α for 1 hr in an ex‐vivo 
setting, while untreated tissues acted as controls. Gene expression of claudin 3 (Cldn3), claudin 5 (Cldn5), junctional adhesion molecule‐A 
(JAM‐A) and occludin (Ocldn) was assessed by qPCR and expressed as a fold change relative to untreated older colons (n = 5/group). (f) To 
examine whether TNF‐α can alter intestinal permeability in vivo, recombinant TNF‐α (20 µg/kg) or saline as control was administered (i.p.) 
immediately following blood reperfusion to young MCAO and sham‐operated mice. Serum levels of orally gavaged FITC‐dextran were 
quantified to examine colon permeability. Data represent the mean ± SEM. Significance was determined by one‐way ANOVA with post hoc 
comparison and Holm–Sidak multiple testing correction. A p‐value	≤	0.05	was	considered	statistically	significant:	*p	≤	0.05,	***p	≤	0.001	and	
§p	≤	0.1	considered	a	significant	trend
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villi, with functional impairment of isolated intestinal epithelial stem 
cells, suggesting a reduced capacity for tissue repair following injury 
(Moorefield et al., 2017).
Given that the gut barrier integrity and intestinal inflammatory 
balance are closely linked with gut microbiome, it is possible that 
age‐dependent alterations in the microbiota further influence stroke 
outcomes. It is known that older individuals have a very different gut 
microbiota profile compared to healthy adults. Generally, the gut mi‐
crobiome of elderly individuals is characterized by reduced bacterial 
diversity with a shift towards lower levels of beneficial populations 
such as bifidobacteria, and this is associated with increased frailty 
(Jackson et al., 2016; Nagpal et al., 2018). The mechanism of micro‐
biota change with aging is not well understood, but it is thought that 
factors associated with cell senescence, immune changes, co‐mor‐
bidities, intestinal physiology and lifestyle play a role. Several recent 
studies using high‐throughput gene sequencing tools demonstrated 
that stroke induces robust changes to the intestinal mucosal mi‐
crobiota, with an overall reduction in species diversity (Singh et al., 
2016; Stanley et al., 2018). Furthermore, it is important to remem‐
ber that brain‐gut communication is bidirectional, with emerging 
evidence showing that disruption of microbial‐host symbiosis prior 
to stroke also leads to altered infarct severity after cerebral isch‐
aemia (Benakis et al., 2016).
A better understanding of age‐associated alterations in muco‐
sal microbiota composition, and their reciprocal impact on the host 
biological pathways, will assist in designing novel and targeted ther‐
apeutic approaches to reduce neurological damage and infectious 
complications after stroke.
4  | E XPERIMENTAL PROCEDURES
4.1 | Patient sampling, data evaluation and analysis
A retrospective cohort design was used, where all information was 
obtained from scanned medical and electronic records available at 
the time of data collection. All patients primarily admitted for an acute 
stroke to Monash Medical Centre between 16 January 2015 and 10 
February 2016 were enrolled and the data present here is a subset 
of a recent published clinical study (Phan et al., 2019). Multivariable 
logistic regression was used to determine the association between 
F I G U R E  6   Stroke results in the 
translocation of intestinal bacteria for 
systemic dissemination in older animals. 
(a) Three hours after mid‐cerebral artery 
occlusion (MCAO) or sham surgery, young 
and older mice were orally inoculated with 
streptomycin‐resistant derivative of the 
Escherichia coli strain DLL206, at a time 
point when gut permeability was evident. 
The (b) caecum, (c) faeces, (d) colon and 
(e) lung were assessed 24 hr later for 
the presence and load of streptomycin‐
resistant E. coli. n = 5–6/group. Data 
represent the mean ± SEM (log‐scale). 
Significance was determined by one‐way 
ANOVA with post hoc comparison and 
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stroke and the presence of infection after adjusting for confounding 
factors. The patient retrospective study was approved by Monash 
Health Human Research Ethics Committee. See Data S1 for details 
on patient sampling, data evaluation and analysis.
4.2 | Mice
Young (7–10 weeks) and older (12–15 months) male C57BL/6J 
mice were obtained and housed by the Monash Animal Research 
Platform (MARP) under specific‐pathogen‐free (SPF) conditions. All 
naïve young mice were housed in groups of no more than five ani‐
mals in each cage after weaning, while older mice were individually 
housed. Water and food pellets (Irradiated Rat and Mouse, Specialty 
Feeds, Australia) were provided ad libitum, and cages were changed 
weekly. All animal procedures were conducted in accordance with 
Australian National Health and Medical Research regulations on the 
use and care of experimental animals, and approved by the Monash 
University Animal Ethics Committee (MMCB/2016/10).
4.3 | Mouse focal cerebral ischaemia model
The mid‐cerebral artery occlusion (MCAO) model was performed 
as previously described (Nicholls, Wen, Hall, Hickey, & Wong, 2018; 
Stanley et al., 2016, 2018). Young and older animals were given 20 min 
of MCAO followed by reperfusion to model a mild form of ischaemic 
stroke, resulting in <10% mortality in both groups to avoid survival 
bias in our study. Sham‐operated animals underwent anaesthetic, 
neck incision and artery isolation only. All animals were individually 
housed after MCAO or sham surgery. See Data S1 for surgical details.
To examine whether TNF‐α can alter intestinal permeability in 
vivo, recombinant TNF‐α (20 µg/kg) or saline as control was ad‐
ministered (i.p.) immediately following blood reperfusion to young 
stroke and sham‐operated mice.
4.4 | Magnetic resonance imaging
Oedema volumes were measured using MRI 24 hr after MCAO in 
young and older mice. Measurements of oedema exclude the volume 
of the ventricle at the dorsal section of the infarct brain hemisphere. 
See Data S1 for MRI scanning procedure and settings.
4.5 | Neurological assessment
At 24 hr after MCAO, neurological assessment was performed on 
young and older mice using an established six‐point scoring system 
(Kim et al., 2014). See Data S1 for scoring parameters.
4.6 | Gut permeability assay
Mice were orally gavaged with 500 mg/kg of 4.4‐kDa fluores‐
cein‐isothiocyanate‐labelled dextran (FITC–dextran; Sigma) at 
2 hr after MCAO. Animals were anesthetized with isoflurane at 
1 hr (small intestine permeability) or 4 hr (colon permeability) after 
gavage, and a cardiac puncture performed to collect serum. Serum 
concentrations of FITC–dextran were determined relative to a 
standard curve (top standard at 1,250 µg/ml) at an excitation of 
485 nm.
4.7 | Vascular permeability assay
At 24 hr after MCAO, animals were given an intravenous injection of 
4 ml/kg 2% Evans blue (Sigma) in saline. Mice were then transcardi‐
ally perfused with saline at 4 hr after Evans blue injection. The whole 
colon was homogenized in 3 ml of N,N‐dimethylformamide (Sigma) 
and further incubated in N,N‐dimethylformamide overnight at 55°C. 
Supernatant containing Evans blue was collected by centrifugation 
at 500 g for 10 min, and concentrations of Evans blue determined 
relative to a standard curve (top standard at 1,000 µg/ml) at an ex‐
citation of 620 nm.
4.8 | Colon histological scoring
At 24 hr after MCAO, a section of the distal colon was collected for 
haematoxylin and eosin (H&E) staining. For each sample, two repre‐
sentative images of colonic crypts at 100× magnification were cap‐
tured using the Leica DM LB widefield microscope and MC120 HD 
camera (Leica) for histological scoring in a blinded manner. Parameters 
for histology scoring were previously established (Shen et al., 2018) 
and detailed in Data S1. Total overall score indicates the degree of co‐
lonic pathology after MCAO or sham operation.
4.9 | Periodic acid‐Schiff staining
At 24 hr after MCAO, a section of the distal colon was collected 
for Periodic acid‐Schiff reagent (PAS) staining according to standard 
protocols. For each sample, two representative images of colonic 
crypts at 100× magnification were captured using the Leica DM LB 
widefield microscope and MC120 HD camera (Lecia). The number of 
goblet cells per colonic crypt was quantified and presented as num‐
ber of cells per mm2.
4.10 | RNA isolation and RT–qPCR
qRT–PCR was performed with standard protocols (Nicholls et 
al., 2018) using the Power SYBR Green PCR Master Mix (Applied 
Biosystems), targeting expression of 18S, occludin, claudin 3, claudin 
5, junctional adhesion molecule‐A, mucin 2, mucin 4 and mucin 13. 
Primer sequences are detailed in Table S3. Data were normalized 
to housekeeping gene 18S and analysed using the 2(−ΔΔCt) method. 
Gene expression was expressed as fold change relative to colon tis‐
sue from sham‐operated animals.
4.11 | Immunofluorescence staining
OCT‐embedded colon sections were stained for the expression 
of ZO‐1 (1:100; ThermoFisher 61‐7300), CD32 (EpCAM, 1:500; 
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ThermoFisher 14‐5791‐81) and DAPI (Sigma 10236276001). See Data 
S1 for detailed staining protocol. ZO‐1 expression was quantified 
using representative images taken on the Nikon C1 Invert confocal 
microscope (Nikon) at a magnification of 400×. Images were captured 
using a pattern which ensured unbiased selection and no overlap. 
Approximately 6–8 images were captured for each colon section for 
analysis and averaged. imagej (NIH) was used for image processing to 
quantify the area of ZO‐1 respective to area of DAPI staining.
4.12 | Inoculation of bacteria
To investigate the potential translocation of bacteria after stroke, 
1010 colony‐forming units (c.f.u.) of the streptomycin‐resistant E. coli 
strain DLL206 was inoculated into mice via oral gavage 3 hr after 
sham or MCAO surgery. The detection of streptomycin‐resistant 
E. coli from various tissues (lung, duodenum, jejunum, ileum, caecum 
and faecal) was performed 22 hr later by plating tissue homogenates 
on 2YT agar plates containing 100 μg/ml streptomycin.
4.13 | Bacteriological analysis
At the time of cull, mice were washed with 70% ethanol under sterile 
conditions. Lungs, duodenum, jejunum, ileum, caecum and/or faecal 
pellet were collected and homogenized in sterile PBS. For determination 
of colony‐forming units (c.f.u.), tissue homogenate was serially diluted 
in PBS and plated onto brain–heart infusion (BHI) agar plates supple‐
mented with 5% sheep blood (for determination of bacterial load in 
poststroke mice) or 2YT agar plates containing streptomycin (for E. coli 
inoculation experiments), incubated at 37°C for 18 hr and counted to 
quantify the number of streptomycin‐resistant E. coli colonies.
4.14 | Enzyme‐linked immunosorbent assay
Protein concentrations of IgA, tumour necrosis factor (TNF)‐α 
and interleukin (IL)‐10 in colonic tissue were measured using 
the Bethyl Laboratories IgA enzyme‐linked immunosorbent 
assay (ELISA) Kit (Bethyl Laboratories), Mouse TNF ELISA Set II 
(BD Biosciences; Cat.558534) and Mouse IL‐10 ELISA Set (BD 
Biosciences; Cat.555252) respectively, according to the manufac‐
turer's instructions.
4.15 | Cytometric bead array
Serum cytokine levels of TNF‐α, IL‐10 and IL‐6 were measured using 
the BD Cytometric bead array (CBA) Mouse Th1/Th2/Th17 Cytokine 
Kit (BD Biosciences) according to the manufacturer's instructions. 
The LSR‐Fortessa (BD Biosciences) and FlowJo (Tree Star) were used 
for acquisition/analysis.
4.16 | Flow cytometry of colon leucocytes
Single‐cell suspensions for flow cytometry were prepared as 
previously described (Shen et al., 2018) and detailed in Data 
S1. Leucocytes were stained with CD45‐PE (30‐F11; eBiosci‐
ence), CD11b‐FITC (M1/70; BioLegend), CD3‐APC (145‐2C11; BD 
Biosciences), Ly6C‐APC Cy7 (AL‐21; BD Biosciences) and Ly6G‐
BV510 (1A8; BioLegend), together with Fc receptor blocking using 
anti‐CD16/32 before resuspension in FACS buffer containing 2% 
FBS and viability dye (7‐aminoactinomycin D; 7‐AAD). The LSR‐
Fortessa (BD Biosciences) and FlowJo (Tree Star) were used for 
acquisition/analysis.
4.17 | Ex‐vivo assessment of TNF‐α on colonic tight 
junction complexes
Colons of naïve older (12–15 months) male C57BL/6J mice were 
carefully excised, dissected into 1 cm cross sections, faecal mat‐
ter gently removed and placed in carbonated Krebs buffer sup‐
plemented with 2 g/L d‐glucose. Carbonated Krebs buffer is 
considered the most biorelevant buffer system for the simulation 
of intestinal conditions (Fadda, Merchant, Arafat, & Basit, 2009). 
Colon cross sections were submerged into 1 ml of Krebs buffer 
(1 ml) and treated for a total of 1 hr with either 0 or 1 ng of re‐
combinant mouse TNF‐α (BioLegend). During treatment, the Krebs 
buffer and colon sections were constantly carbonated at the right 
pH to ensure tissue viability. Following treatment, tissues were 
processed for qRT–PCR to examine the role of TNF‐α on tight junc‐
tion complex expression.
4.18 | Statistics
Quantitative data for experimental mouse studies are presented as 
mean ± standard error of the mean (SEM). Statistical analyses were 
conducted using graphpad prism Software. Data sets were tested for 
normality using the Shapiro–Wilk normality test. Nonparametric 
data were analysed using the Mann–Whitney U test. Comparisons 
of multiple parametric data sets were analysed using one‐way analy‐
sis of variance (ANOVA) with post hoc comparison with Holm–Sidak 
multiple testing correction. Single comparisons of parametric data 
sets were analysed using the Student t test. Adjusted p‐value	≤0.05	
was considered statistically significant.
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